新闻中心

Plexium Announces $102m Financing to Advance Pipeline of Targeted Protein Degradation Therapies and Technology Platform

2022-2-23

OncXerna is selected as Global Top 5 Precision Medicine Startups

2022-2-17

Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients

2022-1-10

鼎丰生科资本领投成立合资公司SanReno Therapeutics

2021-12-03

艾博兹医药完成7,500万美元的A轮融资，将为大中华市场的肿瘤患者带来创新靶向放射性治疗药物

2021-11-29

Zenas BioPharma从Xencor获得Obexelimab的全球独家权利

2021-11-23

极目生物合作伙伴Clearside Biomedical葡萄膜炎性黄斑水肿治疗药物XIPERE™（ARVN001）美国获批上市

2021-10-26

极目生物获得国内首项老视药物疗法ARVN003三期临床试验申请批准

2021-9-03

极目生物脉络膜上腔注射疗法ARVN001获东盟十国及印度独家权益

2021-8-15

QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements

2021-8-09

Engrail Therapeutics Extends Series A Financing to $64 Million

2021-8-03

极目生物低浓度阿托品儿童近视疗法ARVN002三期临床试验申请获批，创新微量给药技术助力近视防控

2021-8-02

神领锐医药宣布获得Neurolief公司的Relivion®在大中华区和韩国开发及商业化的独家许可协议

2021-7-09

Exscientia announces investment of up to $525M

2021-4-26

Evommune完成1250万美元种子轮融资

2020-11-20

Oncologie（鼎航医药）公布最新临床研究数据

2020-9-21

Arctic Vision Announces US$32MN in Series A

2020-7-14

Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China

2018-6-07

Pivotal bioVenture Partners China Closes Inaugural $150 Million Early Stage VC Fund

2018-5-24